Erdag Gulsun, Morgan Jeffrey R
Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children, Boston, MA, 02114, USA.
Cell Transplant. 2004;13(6):701-12. doi: 10.3727/000000004783983594.
There are conflicting reports on the survival and immune reaction to allografts and xenografts of cultured skin substitutes (CSS). In this study, we investigated the allogeneic and xenogeneic responses to CSS of human keratinocytes and genetically engineered CSS expressing keratinocyte growth factor (KGF) that forms a hyperproliferative epidermis. CSS (control and KGF modified) and neonatal human foreskins were evaluated by immunohistochemistry for the expression of MHC class I and II. To study allograft rejection, grafts were transplanted to human peripheral blood mononuclear cell (huPBMC)-reconstituted SCID mice. To study xenograft rejection, grafts were transplanted to immunocompetent mice. Graft survival and immune reaction were assessed visually and microscopically. After transplantation, control CSS formed a normal differentiated epidermis, whereas KGF CSS formed a hyperproliferative epidermis. Control and KGF CSS expressed class I similar to neonatal foreskin, but did not express class II. In the allograft model, rejection of neonatal foreskins was between 5 and 9 days. In contrast, neither control nor KGF CSS was rejected by huPBMC-SCID mice. Histology showed dense mononuclear cell infiltration in human foreskins, with few, if any, mononuclear cells in control or KGF CSS. In contrast to the allogeneic reaction, CSS (control and KGF) were rejected in the xenograft model, but rejection was delayed (9-21 days) compared with neonatal skin (5-8 days). Humanized SCID mice rejected allografts of human neonatal foreskins, but did not reject control CSS or KGF CSS, even though the KGF CSS formed a hyperproliferative epidermis. Rejection of control and KGF CSS by immunocompetent mice in a xenograft model was comparable and their survival was significantly prolonged compared with neonatal skin. These results demonstrate that control CSS and hyperproliferative KGF CSS are less immunogenic than normal human skin and that sustained hyperproliferation of the epidermis does not accelerate rejection.
关于培养皮肤替代物(CSS)同种异体移植和异种移植的存活情况及免疫反应,存在相互矛盾的报道。在本研究中,我们调查了人角质形成细胞以及表达角质形成细胞生长因子(KGF)并形成增殖性表皮的基因工程化CSS对同种异体和异种CSS的反应。通过免疫组织化学评估CSS(对照和KGF修饰)以及新生儿人类包皮中MHC I类和II类的表达。为研究同种异体移植排斥反应,将移植物移植到用人外周血单个核细胞(huPBMC)重建的SCID小鼠体内。为研究异种移植排斥反应,将移植物移植到具有免疫活性的小鼠体内。通过肉眼和显微镜评估移植物存活情况及免疫反应。移植后,对照CSS形成正常分化的表皮,而KGF CSS形成增殖性表皮。对照和KGF CSS表达的I类与新生儿包皮相似,但不表达II类。在同种异体移植模型中,新生儿包皮的排斥发生在5至9天之间。相比之下,huPBMC - SCID小鼠既未排斥对照CSS,也未排斥KGF CSS。组织学显示人类包皮中有密集的单核细胞浸润,而对照或KGF CSS中几乎没有单核细胞。与同种异体反应不同,CSS(对照和KGF)在异种移植模型中被排斥,但与新生儿皮肤(5至8天)相比,排斥延迟(9至21天)。人源化SCID小鼠排斥人类新生儿包皮的同种异体移植,但不排斥对照CSS或KGF CSS,尽管KGF CSS形成了增殖性表皮。在异种移植模型中,具有免疫活性的小鼠对对照和KGF CSS的排斥情况相当,并且与新生儿皮肤相比,它们的存活时间显著延长。这些结果表明,对照CSS和增殖性KGF CSS的免疫原性低于正常人类皮肤,并且表皮的持续增殖不会加速排斥反应。